Neurology

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Patients With Developmental and/or Epileptic Encephalopathies

Conditions:   Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Interventions:   Drug: TAK-935;   Drug: Placebo
Sponsors:   Takeda;   Ovid Therapeutics Inc.
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 4, 2018 / by / in
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Conditions:   Glioblastoma;   Glioblastoma With Primitive Neuronal Component;   Gliosarcoma;   Malignant Glioma;   Oligodendroglial Component Present
Interventions:   Drug: Plerixafor;   Drug: Temozolomide;   Radiation: Whole-Brain Radiotherapy (WBRT);   Radiation: Radiation Therapy
Sponsor:   Lawrence Recht
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 1, 2018 / by / in